C12Y 304/24079
Pappalysin-1
Official title: Pappalysin-1 (3.4.24.79)
C12Y304/24079 (Pappalysin-1) appears on 2 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 6
- Assignees
- 3
- Inventors
- 13
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Antigen binding proteins6 Aug 2026US 2026/0226194 A1GlaxoSmithKline Intellectual Property Development Limited
- Antigen binding proteins27 Nov 2025US 2025/0361323 A1GlaxoSmithKline Intellectual Property Development Limited
- Methods of Treating Retinal Vasculopathies25 Jul 2024US 2024/0245680 A1
- Methods for screening embryos14 Sep 2023US 2023/0287494 A1
- Pappalysin regulator20 Aug 2020US 2020/0261490 A1Aarhus Universitet
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.